SI Septerna, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Septerna, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 3 September 2026 (Levée d'options). Among the most active insiders: Bhatt Elizabeth. All data is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Septerna, Inc. Strong Buy (bullish), based on 9 analysts. Average price target: US$54.22.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
All Executives42 Thresholds0 Prospectus0 Other0
Declarations 42 total
◇ SVP, Drug Discovery · Executives · 1 Sept 2026
3,333 shares @ US$2.76 Common Stock SEC:0001193125-26-382267:0
▼ SVP, Drug Discovery · Executives · 1 Sept 2026
3,333 shares @ US$37.8271 Common Stock SEC:0001193125-26-382267:1
▼ Director · Executives · 12 Aug 2026
746,500 shares @ US$42.50 1.51% mcap 100.0% of flow Common Stock SEC:0001231919-26-000938:0
▼ 10% Owner · Executives · 12 Aug 2026
141 shares @ US$51.08 0.0003% mcap 0.0% of flow Common Stock SEC:0001193125-26-352692:1
▼ Director · Executives · 12 Aug 2026
746,500 shares @ US$42.50 Common Stock SEC:0001231919-26-000938:1
▼ 10% Owner · Executives · 12 Aug 2026
147,059 shares @ US$50.27 0.35% mcap 49.6% of flow Common Stock SEC:0001193125-26-352692:0
◇ President and COO · Executives · 11 Aug 2026
18,681 shares @ US$6.81 0.0073% mcap 8.2% of flow Common Stock SEC:0001193125-26-349810:0
◇ President and COO · Executives · 11 Aug 2026
6,319 shares @ US$2.76 0.0010% mcap 1.1% of flow Common Stock SEC:0001193125-26-349810:1
▼ President and COO · Executives · 11 Aug 2026
25,000 shares @ US$44.00 0.063% mcap 70.6% of flow Common Stock SEC:0001193125-26-349810:2
● Affiliate · Executives · 12 Aug 2026
746,500 shares @ US$48.19 2.05% mcap 100.0% of flow Common SEC144:0001178937-26-000041
● 10% Stockholder · Executives · 12 Aug 2026
147,200 shares @ US$51.00 0.43% mcap 100.0% of flow Common SEC144:0001974078-26-000301
● affiliate · Executives · 12 Aug 2026
746,500 shares @ US$48.19 2.05% mcap 100.0% of flow Common SEC144:0001178937-26-000042
● Officer · Executives · 11 Aug 2026
29,000 shares @ US$38.85 0.064% mcap 89.0% of flow Common SEC144:0001950047-26-007956
◇ SVP, Drug Discovery · Executives · 3 Aug 2026
1,518 shares @ US$2.76 0.0002% mcap 2.2% of flow Common Stock SEC:0001193125-26-335820:1
◇ SVP, Drug Discovery · Executives · 3 Aug 2026
1,816 shares @ US$2.76 0.0002% mcap 2.7% of flow Common Stock SEC:0001193125-26-335820:0
▼ SVP, Drug Discovery · Executives · 3 Aug 2026
1,000 shares @ US$33.9756 0.0017% mcap 18.1% of flow Common Stock SEC:0001193125-26-335820:2
▼ SVP, Drug Discovery · Executives · 3 Aug 2026
2,334 shares @ US$34.6805 0.0040% mcap 43.2% of flow Common Stock SEC:0001193125-26-335820:3
◇ President and COO · Executives · 15 Jul 2026
4,000 shares @ US$6.81 0.0014% mcap 8.8% of flow Common Stock SEC:0001193125-26-308073:0
▼ President and COO · Executives · 15 Jul 2026
4,000 shares @ US$33.9935 0.0068% mcap 43.8% of flow Common Stock SEC:0001193125-26-308073:1
● Officer · Executives · 15 Jul 2026
4,000 shares @ US$34.54 0.0069% mcap 100.0% of flow Common SEC144:0001950047-26-007101
● Officer · Executives · 26 Jun 2026
2,438 shares @ US$36.605 0.0053% mcap 100.0% of flow Common SEC144:0001950047-26-006526
● Officer · Executives · 22 Jun 2026
94,339 shares @ US$35.2571 0.20% mcap 97.4% of flow Common SEC144:0001950047-26-006351
● Officer · Executives · 22 Jun 2026
25,000 shares @ US$36.17 0.056% mcap 100.0% of flow Common SEC144:0001950047-26-006361
● Officer · Executives · 12 Jun 2026
8,428 shares @ US$34.03 0.017% mcap 100.0% of flow Common SEC144:0001950047-26-006015
◇ President and COO · Executives · 15 Apr 2026
4,000 shares @ US$6.81 0.0016% mcap 21.9% of flow Common Stock SEC:0001193125-26-161987:0
25 of 42 declarations
Load more (17 remaining) 关于 Septerna, Inc. Septerna, Inc. 是一家在 XNAS 市场上市的公司。该公司专注于生物技术领域的创新解决方案开发。